Arvee Laboratories (India) Limited (ARVEE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.56 Million ≈ $146.61K USD) by net assets (Rs314.41 Million ≈ $3.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Arvee Laboratories (India) Limited (ARVEE) total market value for the company's overall valuation and market capitalisation.
Arvee Laboratories (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Arvee Laboratories (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Arvee Laboratories (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arvee Laboratories (India) Limited ranked by their cash flow conversion efficiency. Explore Arvee Laboratories (India) Limited (ARVEE) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dorsavi Ltd
AU:DVL
|
-0.251x |
|
BCWORLD PHARM. Co. Ltd
KQ:200780
|
0.020x |
|
Fredonia Mining Inc
V:FRED
|
0.640x |
|
NHN Bugs Corp
KQ:104200
|
0.033x |
|
Oxford Nanopore Technologies Ltd
LSE:ONT
|
-0.093x |
|
S-Fuelcell co. Ltd
KQ:288620
|
-0.034x |
|
Biofish Holding AS
OL:BFISH
|
0.061x |
|
Only World Group Holdings Bhd
KLSE:5260
|
0.074x |
Annual Cash Flow Conversion Efficiency for Arvee Laboratories (India) Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Arvee Laboratories (India) Limited from 2013 to 2025. View ARVEE live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs312.61 Million ≈ $3.38 Million |
Rs1.19 Million ≈ $12.86K |
0.004x | -96.98% |
| 2024-03-31 | Rs291.14 Million ≈ $3.15 Million |
Rs36.64 Million ≈ $396.20K |
0.126x | +20.56% |
| 2023-03-31 | Rs280.62 Million ≈ $3.03 Million |
Rs29.29 Million ≈ $316.75K |
0.104x | +266.76% |
| 2022-03-31 | Rs239.42 Million ≈ $2.59 Million |
Rs6.81 Million ≈ $73.68K |
0.028x | -64.33% |
| 2021-03-31 | Rs214.38 Million ≈ $2.32 Million |
Rs17.11 Million ≈ $184.99K |
0.080x | -85.57% |
| 2020-03-31 | Rs186.89 Million ≈ $2.02 Million |
Rs103.34 Million ≈ $1.12 Million |
0.553x | -3.74% |
| 2019-03-31 | Rs164.62 Million ≈ $1.78 Million |
Rs94.56 Million ≈ $1.02 Million |
0.574x | +35.56% |
| 2018-03-31 | Rs141.99 Million ≈ $1.54 Million |
Rs60.16 Million ≈ $650.63K |
0.424x | -44.76% |
| 2017-03-31 | Rs41.94 Million ≈ $453.55K |
Rs32.17 Million ≈ $347.88K |
0.767x | -67.47% |
| 2016-03-31 | Rs26.41 Million ≈ $285.60K |
Rs62.26 Million ≈ $673.36K |
2.358x | -61.19% |
| 2015-03-31 | Rs14.15 Million ≈ $153.01K |
Rs85.94 Million ≈ $929.39K |
6.074x | +6203.72% |
| 2014-03-31 | Rs30.62 Million ≈ $331.12K |
Rs-3.05 Million ≈ $-32.95K |
-0.100x | -100.24% |
| 2013-03-31 | Rs930.00K ≈ $10.06K |
Rs38.55 Million ≈ $416.93K |
41.454x | -- |
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more